شنبه 15 اردیبهشت 1403
[Archive]
دوره 6، شماره 4 - ( 4-1387 )
جلد 6 شماره 4 صفحات 0-167 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghahiri A, Sabahi R, Ghasemi M. Long term management of preterm labor with MgSO4 in myomatous uterus. IJRM 2008; 6 (4) :167-0
URL: http://ijrm.ir/article-1-117-fa.html
URL: http://ijrm.ir/article-1-117-fa.html
Long term management of preterm labor with MgSO4 in myomatous uterus. International Journal of Reproductive BioMedicine. 1387; 6 (4) :167-0
چکیده: (2435 مشاهده)
Background: According to the text book of obstetrics and Gynecology, prematurity is the first cause of perinatal mortality. Therefore postponing delivery will become mandatory to prevent complications of prematurity. Parental MgSO4 is one of the most common and the safest medications for this purpose.
Case report: We present a primigravida patient with multiple uterine myoma who had premature labor and received intravenous MgSO4 for 58 days in order to postpone her delivery while having a cervical dilation of 4-5 cm. The patient underwent C/S at the gestational age of 34 weeks because of reducing fetal movements and Breech presentation.
Conclusion: Because of many side effects of long term management with MgSO4 and bed rest, this protocol isn't recommended for all patients.
Case report: We present a primigravida patient with multiple uterine myoma who had premature labor and received intravenous MgSO4 for 58 days in order to postpone her delivery while having a cervical dilation of 4-5 cm. The patient underwent C/S at the gestational age of 34 weeks because of reducing fetal movements and Breech presentation.
Conclusion: Because of many side effects of long term management with MgSO4 and bed rest, this protocol isn't recommended for all patients.
نوع مطالعه: Original Article |
فهرست منابع
1. Wedig KE, Kogan J, Schorry EK, Whitsett JA. Skeletal demineralization and fractures caused by fetal magnesium toxicity. J Perinatol 2006; 26: 371-374. [DOI:10.1038/sj.jp.7211508]
2. Matsuda Y, Nagayoshi Y, Kirihara N. Rhabdomyolysis during prolonged intravenous tocolytic therapy. J Perinat Med 2002; 30: 514-516. [DOI:10.1515/JPM.2002.080]
3. Levar AL, Chan L, Wapner RJ. Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report. Am J Perinatol 1998; 15:43-46. [DOI:10.1055/s-2007-993897]
4. Koontz SL, Friedman SA, Schwartz ML. Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine. Am J Obstet Gynecol 2004; 190:1773- 1776. [DOI:10.1016/j.ajog.2004.02.050]
5. Kovacevich GJ, Gaich SA, Lavin JP, Hopkins MP, Crane SS, Stewart J, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes.Am J Obstet Gynecol 2000; 182:1089- 1092. [DOI:10.1067/mob.2000.105405]
6. Carr MH, Towers CV, Eastenson AR, Pircon RA, Iriye BK, Adashek JA. Prolonged bedrest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis? J Matern Fetal Med 1997; 6:264-267. [DOI:10.3109/14767059709161999]
7. Laros RK. Thromboembolic disease. in: Greasy RK, Rensik R, editors maternal - fetal medicine. 4th ed. Philadelphia: WB saunders; 1999; 821-831.
8. Qidwai GI, Caughey AB, Jacoby AF. Obstetric outcomes in women with sonographically identified uterine leiomyomata.Obstet Gynecol 2006; 107:376-382. [DOI:10.1097/01.AOG.0000196806.25897.7c]
9. Ouyang DW, Economy KE, Norwitz ER. Obstetric complications of fibroids. Obstet Gynecol Clin North Am 2006; 33:153-169. [DOI:10.1016/j.ogc.2005.12.010]
10. Boser D, Dimitrov A. Changes in uterine myoma dimensions during pregnancy. Akush Ginekol (Sofiia) 2007; 46:3-6.
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
